SIRT1 and muscle insulin sensitivity
SIRT1 和肌肉胰岛素敏感性
基本信息
- 批准号:8372767
- 负责人:
- 金额:$ 29.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2017-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAddressAdverse effectsAdvocateAgeAgingAttenuatedBioinformaticsBiological AssayBiologyCaloric RestrictionComplicationDataDeacetylaseDeacetylationDefectDeoxyglucoseDietDiseaseEatingEtiologyEuglycemic ClampingFosteringGenetic TranscriptionGlucose ClampHealthHumanIndividualInsulinInsulin ResistanceInsulin Signaling PathwayIntakeKnock-outKnowledgeLinkLysineMass Spectrum AnalysisMeasurementMeasuresMediatingMetabolicModelingMusMuscleMuscle CellsNon-Insulin-Dependent Diabetes MellitusOlder PopulationPathogenesisPathway interactionsPhosphatidylinositolsPhosphotransferasesProteinsQuality of lifeRegulationResearchRiskRoleSignal PathwaySignal TransductionSignaling MoleculeSite-Directed MutagenesisSkeletal MuscleStat3 proteinSystems BiologyTNFRSF5 geneTechniquesTherapeuticTransgenic MiceUnited Statesage effectagedanti agingbasedefined contributiondesignfeedingglucose transporthuman MPP1 proteinimprovedin vivoinsulin sensitivityinsulin signalingmouse modelmuscle agingnoveloverexpressionpreventresearch studyresponsetherapy developmentuptake
项目摘要
DESCRIPTION (provided by applicant): Insulin resistance is a common metabolic complication in aged muscle, and is a primary defect underlying the etiology of type 2 diabetes (T2D). However, the signaling mechanisms in muscle linking age to insulin resistance are unknown. Considering that in 2010, ~27% of individuals 65 yrs and older in the United States were afflicted with T2D, and in the next 20 years the 65 and older population is anticipated to double to ~70 million, it is imperative that this fundamental gap in knowledge be resolved. Thus, the long-term objective of this research is to define the mechanisms underlying muscle insulin resistance in aging. Caloric restriction (CR; defined as 60% of ad libitum [AL] food intake) robustly reverses muscle insulin resistance, and delays its onset during aging. The NAD+-dependent protein deacetylase, sirtuin 1 (SIRT1) is activated by CR, and is thought to be the putative signaling node linking age and CR to muscle insulin action. Surprisingly, however, knowledge regarding the regulatory role of SIRT1 on muscle insulin action, particularly, in vivo, is remarkably limited. Our central hypothesis is that SIRT1 is a key signaling molecule that links aging and CR to muscle insulin action, primarily by modulating the acetylation of major signaling nodes, such as signal transducer and activator of transcription 3 (STAT3), that then influence many signaling pathways, including the insulin signaling pathway. To address this hypothesis, our approach will be to study muscle insulin signaling and sensitivity in response to age and CR using novel mouse models, in which we have manipulated SIRT1 activity specifically in muscle. Our model predicts that changes in SIRT1 activity during aging, and in response to CR, leads to changes in the acetylation status and subsequent activity of SIRT1 target proteins, which directly or indirectly regulates muscle insulin signaling and sensitivity. Specifically, Aim #1 wil elucidate the contribution of SIRT1 and STAT3 to the pathogenesis of muscle insulin resistance in aging mice, whilst Aim #2 will determine whether a SIRT1- STAT3 signaling axis underlies the ability of CR to enhance muscle insulin sensitivity in mice. For these studies, we will measure muscle insulin signaling and insulin sensitivity, in vivo, using hyperinsulinemic- euglycemic clamps, and ex vivo, using 2-deoxyglucose uptake assays, in young (4 months), mid-aged (12 months) and old (20 months) mice fed an AL diet, and compare them to measurements in mice fed a short- term (30 d) or long-term (9 or 17 months) CR diet. Studies will be conducted in 4 different transgenic mice with either a muscle-specific increase of SIRT1 activity, knockout (KO) of SIRT1 deacetylase activity, KO of STAT3 or KO of SIRT1 and STAT3. In Aim #3, we will use mass spectrometry techniques and adenoviral-based studies in muscle cells to identify novel targets of SIRT1 and the functional effects of their acetylation on insulin action. Altogether, these studies will broaden our understanding of the role of SIRT1 in muscle biology, and may have wide-reaching impact on the development of therapies to treat not only muscle insulin resistance, but also other diseases of aging in skeletal muscle.!
PUBLIC HEALTH RELEVANCE: Insulin resistance is a common metabolic defect in aged muscle that increases the risk for developing type 2 diabetes. These experiments aim to define why aging muscle becomes insulin resistant, and to define how caloric restriction reverses this insulin resistance, with particular focus on the "anti-aging" protein, SIRT1. Knowledge gathered by such studies will allow the design of improved therapies to treat insulin resistance.!
描述(由申请人提供):胰岛素抵抗是衰老肌肉中常见的代谢并发症,是2型糖尿病(T2D)病因的主要缺陷。然而,肌肉中将年龄与胰岛素抵抗联系起来的信号机制尚不清楚。考虑到2010年,美国65岁及以上人群中约有27%的人患有T2D,而在未来20年,65岁及以上人口预计将翻一番,达到约7000万,解决这一根本性的知识差距势在必行。因此,本研究的长期目标是确定衰老过程中肌肉胰岛素抵抗的机制。热量限制(CR;定义为随意[AL]食物摄入的60%)强有力地逆转肌肉胰岛素抵抗,并延缓其在衰老过程中的发生。NAD+依赖性蛋白去乙酰化酶sirtuin 1 (SIRT1)被CR激活,被认为是连接年龄和CR与肌肉胰岛素作用的推定信号节点。然而,令人惊讶的是,关于SIRT1对肌肉胰岛素作用的调节作用的知识,特别是在体内,非常有限。我们的中心假设是SIRT1是一个关键的信号分子,将衰老和CR与肌肉胰岛素作用联系起来,主要通过调节主要信号节点的乙酰化,如信号转换器和转录激活器3 (STAT3),然后影响许多信号通路,包括胰岛素信号通路。为了解决这一假设,我们的方法将是使用新型小鼠模型研究肌肉胰岛素信号传导和对年龄和CR的敏感性,在这种模型中,我们特别控制了肌肉中的SIRT1活性。我们的模型预测,衰老过程中SIRT1活性的变化,以及对CR的反应,导致SIRT1靶蛋白乙酰化状态和随后活性的变化,从而直接或间接调节肌肉胰岛素信号传导和敏感性。具体来说,Aim #1将阐明SIRT1和STAT3在衰老小鼠肌肉胰岛素抵抗发病机制中的作用,而Aim #2将确定SIRT1- STAT3信号轴是否支持CR增强小鼠肌肉胰岛素敏感性的能力。在这些研究中,我们将在体内使用高胰岛素-正糖钳测量肌肉胰岛素信号和胰岛素敏感性,在体外使用2-去氧葡萄糖摄取测定,在年轻(4个月),中年(12个月)和老年(20个月)饲喂AL饮食的小鼠中,并将其与饲喂短期(30天)或长期(9或17个月)CR饮食的小鼠进行比较。研究将在4种不同的转基因小鼠中进行,其中SIRT1活性的肌肉特异性增加,SIRT1去乙酰化酶活性的敲除(KO), STAT3的KO或SIRT1和STAT3的KO。在Aim #3中,我们将在肌肉细胞中使用质谱技术和基于腺病毒的研究来鉴定SIRT1的新靶点及其乙酰化对胰岛素作用的功能影响。总之,这些研究将拓宽我们对SIRT1在肌肉生物学中的作用的理解,并可能对治疗肌肉胰岛素抵抗以及其他骨骼肌衰老疾病的治疗方法的发展产生广泛的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Simon Schenk其他文献
Simon Schenk的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Simon Schenk', 18)}}的其他基金
Mechanistic study of skeletal muscle proteolysis induced by breast cancer-secreted extracellular vesicles
乳腺癌分泌的细胞外囊泡诱导骨骼肌蛋白水解的机制研究
- 批准号:
10704327 - 财政年份:2022
- 资助金额:
$ 29.28万 - 项目类别:
Acetylation and contraction-mediated glucose uptake
乙酰化和收缩介导的葡萄糖摄取
- 批准号:
10490253 - 财政年份:2021
- 资助金额:
$ 29.28万 - 项目类别:
Acetylation and contraction-mediated glucose uptake
乙酰化和收缩介导的葡萄糖摄取
- 批准号:
10155065 - 财政年份:2021
- 资助金额:
$ 29.28万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 29.28万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 29.28万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 29.28万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 29.28万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 29.28万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 29.28万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 29.28万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 29.28万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 29.28万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 29.28万 - 项目类别:
Research Grant